Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test
Cost: AED 2310.0
Introduction
The Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test is a diagnostic test offered by DNA Labs UAE. This test is designed to detect and differentiate between three sexually transmitted infections (STIs) – Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. Early and accurate detection of these STIs is crucial for prompt treatment and prevention of complications.
Test Details
The Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test is based on the detection of the genetic material (RNA) of these bacteria in a patient’s sample. The sample can be obtained from various sites of infection, such as genital swab, urine sample, cervical discharge, rectum, urethra, blood, etc. The test uses a multiplex assay, allowing for the simultaneous detection and differentiation of multiple pathogens in a single test. It is a qualitative test, providing information on the presence or absence of the targeted pathogens in the sample. However, it does not provide information on the quantity or severity of the infection.
Advantages of the Test
The Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test offers several advantages over traditional diagnostic methods. It has increased sensitivity, specificity, and efficiency. The test enables faster diagnosis by detecting multiple pathogens in a single test, reducing the need for multiple tests. This test specifically detects RNA, which is the genetic material of the bacteria. Other diagnostic methods, such as nucleic acid amplification tests (NAATs), may also be used to detect and diagnose these STIs, but they may target different components of the bacteria (e.g., DNA).
Pre Test Information
Prior to undergoing the Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test, individuals are required to sign a consent document and provide any relevant clinical history of the patient for Chlamydia trachomatis, N. gonorrhoea, M. genitelium Multiplex Detection & Differentiation (RNA Detection) Qualitative Test.
Report Delivery
The report for the Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test is typically delivered via email within 4 working days. Alternatively, it can be obtained over the phone within 36 hours.
Conclusion
The Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test offered by DNA Labs UAE is a reliable and efficient diagnostic tool for the detection and differentiation of three common sexually transmitted infections. Early detection and appropriate treatment are essential for the individual’s health and for preventing the spread of these infections to others. Regular screening is recommended for individuals at risk of these STIs.
| Test Name | Chlamydia trachomatis N. gonorrhoeaM. genitelium Multiplex Detection and Differentiation RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 2310.0 AED |
| Sample Condition | urethral or vaginal swab, cell culture, cervical discharge, rectum, urethra, blood, Urine, etc |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forChlamydia trachomatis, N. gonorrhoea,M. genitelium Multiplex Detection & Differentiation (RNA Detection) QualitativeTest |
| Test Details |
The Chlamydia trachomatis, N. gonorrhoea, M. genitelium Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between the RNA of three different sexually transmitted infections (STIs) – Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. This test is based on the detection of the genetic material (RNA) of these bacteria in a patient’s sample, typically obtained from the site of infection (e.g., genital swab, urine sample). It uses a multiplex assay, which means that it can detect and differentiate between multiple pathogens in a single test. The test is qualitative, meaning that it can determine the presence or absence of the targeted pathogens in the sample. It does not provide information on the quantity or severity of the infection. Early and accurate detection of these STIs is crucial for prompt treatment and prevention of complications. Chlamydia trachomatis is the most common bacterial STI globally, while Neisseria gonorrhoeae and Mycoplasma genitalium are also prevalent and can cause serious health problems if left untreated. The Multiplex Detection & Differentiation test offers several advantages over traditional diagnostic methods, such as increased sensitivity, specificity, and efficiency. It allows for the simultaneous detection of multiple pathogens in a single test, reducing the need for multiple tests and enabling faster diagnosis. It is important to note that this test specifically detects RNA, which is the genetic material of the bacteria. Other diagnostic methods, such as nucleic acid amplification tests (NAATs), may also be used to detect and diagnose these STIs, but they may target different components of the bacteria (e.g., DNA). It is recommended that individuals at risk of these STIs, such as sexually active individuals or those with symptoms, undergo regular screening to ensure early detection and appropriate treatment. Testing and treatment are crucial not only for the individual’s health but also for preventing the spread of these infections to others. |
